Chun-Xin Lei

Chun-Xin Lei

Auto-generated profile, based on publicly available information

Chun-Xin Lei

Graduate School, Beijing University of Chinese Medicine, Beijing, 100029, China

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 January 2026 in Biology of Sex Differences
Verified
Journal Article
Open access
PDF file
CLChunxin Lei
Chunxin Lei
XZXiya Zhang
Xiya Zhang
YZYan Zhang
Yan Zhang
YFYunlong Fang
Yunlong Fang
JCJiaqi Chen
Jiaqi Chen
JLJing Luo
Jing Luo
Objective: To assess the impact of sex on mortality and malignancy in patients with primary Sjögren’s disease (pSD). Methods: This ambispective cohort study included 1,182 pSD patients (1,025 women and 157 men) from the China–Japan Friendship Hospital between 2014–2023 and followed through 2024. Survival outcomes were estimated via Kaplan–Meier curves, and SMRs were calculated. Independent risk factors were identified via multivariate Cox regression, followed by stepwise Cox, sex-stratified and interaction analyses. Results: During follow-up, 125 deaths (10.6%) and 33 malignancies (2.8%) occurred, both of which were more common in men (log–rank tests, P < 0.001). Overall mortality was markedly higher in men (25.5%, SMR = 4.79) than in women (8.3%, SMR = 2.42). Male sex was independently associated with higher risk of mortality (HR = 1.998, P = 0.004) and cancer incidence (HR = 3.799, P = 0.001). Sex-stratified analyses revealed distinct death–associated factors: interstitial lung disease (ILD), pulmonary infection and ischemic stroke were independently associated with mortality in men, whereas older age, low C3, elevated C-reactive protein and total bilirubin (TBIL) levels were associated with mortality in women. With respect to cancer, longer disease duration, lymphadenopathy, lymphocytopenia, elevated TBIL and hypochloremia were independently associated with cancer risk in women, whereas no variables showed an independent association with cancer risk among men. Interaction analyses demonstrated additive interactions between male sex and elevated ESSDAI scores, as well as male sex and concomitant ILD, in relation to mortality. Conclusion: Compared with women, men with pSD presented greater risks and distinct risk profiles of death and malignancy. Moreover, male sex was independently associated with adverse outcomes and acted as an important effect modifier, highlighting the need for sex-specific risk stratification and clinical management. Trial registration: This ambispective cohort study was registered in the Clinical Trial Registry (ID: NCT06528197) on June 27, 2024 and conducted in accordance with the Declaration of Helsinki.

22 September 2026 in Journal of Autoimmunity
Verified
Journal Article
Closed access
BTBojie Tang
Bojie Tang
YZYan Zhang
Yan Zhang
XYXinbo Yu
Xinbo Yu
CLChunxin Lei
Chunxin Lei
JCJiaqi Chen
Jiaqi Chen
JLJing Luo
Jing Luo

11 May 2026 in Lipids in Health and Disease
Verified
Journal Article
Open access
XZXuan-Yi Zhou
Xuan-Yi Zhou
YZYan Zhang
Yan Zhang
CLChun-Xin Lei
Chun-Xin Lei
ZLZi-Han Liu
Zi-Han Liu
JCJia-Qi Chen
Jia-Qi Chen
JLJing Luo
Jing Luo
Primary Sjögren's disease (pSjD) confers a markedly elevated risk for developing CVD, an important contributor to mortality in this population. This study was designed to identify factors associated with CVD in pSjD and to develop a classification model. In this cross-sectional analysis of pSjD individuals (2013-2023), multivariable logistic regression was used to identify CVD-related factors. A classification model was constructed with variable selection via LASSO regression and the Boruta algorithm. Among 734 patients with pSjD, 192 (26.2%) had CVD. Age (odds ratio [OR]: 1.06, P < 0.001), body mass index (BMI; OR: 1.14, P < 0.001), triglyceride-glucose (TyG) index (OR: 3.49, P < 0.001), and positive anti-Ro52 status (OR: 1.58, P = 0.022) were independent correlates of CVD in pSjD. Moreover, age, BMI, and TyG index showed a trend of gradually increasing CVD risk in patients with pSjD (P < 0.05). A five-variable classification model incorporating age, BMI, TyG index, anti-Ro52 antibody, and corrected QT interval was developed to identify CVD status. Good discrimination (area under the curve: 0.768), proper calibration, and clinical applicability were observed for this model. Its performance remained robust upon internal validation and testing in the test set (area under the curve: 0.753 and 0.821). The TyG index and anti-Ro52 antibody serve as significant factors associated with prevalent CVD in patients with pSjD. A novel classification model that integrates these biomarkers with age, BMI, and corrected QT interval showed good performance and generalizability, and may provide a practical tool for identifying cardiovascular status in this population.

15 October 2025 in International Journal of Rheumatic Diseases
Verified
Journal Article
Closed access
YZYan Zhang
Yan Zhang
QWQin Wang
Qin Wang
CLC.‐X. Lei
C.‐X. Lei
JCJ.‐Q. Chen
J.‐Q. Chen
JLJiahe Liao
Jiahe Liao
QTQingwen Tao
Qingwen Tao